SCHEMBL29535303

SCHEMBL29535303

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.53
▸ LGALS3 P17931 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ NOD2 Q9HC29 1/20 0.39
▸ LGALS8 O00214 1/20 0.37
▸ LGALS4 P56470 1/20 0.37
▸ CD69 Q07108 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535351 1.00 MAPK1 (0.53) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL19521448 0.90 MAPK1 (0.52) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL29535436 0.90 MAPK1 (0.62) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL30694316 0.90 MAPK1 (0.52) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL30694301 0.90 MAPK1 (0.62) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL23631136 0.90 MAPK1 (0.52) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL4258624 0.90 MAPK1 (0.52) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL4322755 0.90 MAPK1 (0.52) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL21067800 0.90 MAPK1 (0.52) MAPK1LGALS3ALDH1A1THRBNOD2
SCHEMBL26597373 0.90 MAPK1 (0.62) MAPK1LGALS3ALDH1A1THRBNOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240366853-A1 METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE EXTHERA MEDICAL CORPORATION (US) 2024-11-07 — — US disclosed
US-12090261-B2 Method for modulating endothelial glycocalyx structure EXTHERA MEDICAL CORPORATION (US) 2024-09-17 — — US disclosed
EP-3969014-A1 METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE ExThera Medical Corporation (US) 2022-03-23 — — EP disclosed
Send feedback